🇬🇧 #1 Economics Think Tank 🎓| Promoting markets, liberty, innovation, progress & growth 🚀| Sign-up here to be notified of our upcoming events 📨 

Adam Smith Institute

We are on the cusp of a major revolution in psychiatric medicine and neuroscience.

​We're delighted to be hosting an exciting series of talks on the legal status of psychedelics. 

, Clinical Director and Deputy Head of Centre for Psychedelic Research and Clinical Senior Lecturer in General Psychiatry in Centres for Neuropsychopharmacology at Imperial. 

David conducts psychopharmacological research, using brain-imaging techniques such as PET and MRI. Since 2009 he has been involved in post-doc imaging research into the neurobiology of addictions and major depression at Imperial. David has been investigating brain mechanisms and therapeutic potential of MDMA, ketamine and classic psychedelics.

, Campaign Manager at Psilocybin Access Rights, has been a psychedelic medicine advocate since 2015, and co-founded PAR in 2022 to improve therapy access. As a Partner at Ogilvy Behavioural Science Practice, she works with top clients and hosts Nudgestock, a leading behavioural science and creativity festival.

, Editor of the Cobden Centre, a British economics think tank founded by Member of Parliament Steve Baker and entrepreneur Toby Baxendale.

After the talks, there will be short panel discussion and Q+A.

 23 Great Smith Street, Westminster. SW1P 3DJ.

RSVPs will be on a first come first served basis, you will receive a confirmation of your ticket if you are allocated a space.

Enlightenment Evenings: Psychedelics at the ASI (well, not really!!)